# Jemperli

NDC: 0173-0898
Generic name: dostarlimab
Labeler / Manufacturer: GlaxoSmithKline LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20210422

FDA application: BLA761174

## Active ingredients

- DOSTARLIMAB: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0173-0898"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0173-0898
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=095eab9f-545a-4f12-bfb7-19477fb901a5
